SILSTEO®, combining Bio-Activated Silicium (Mesoporosil®) with vitamin D3, vitamin K2, and calcium, supports physiological bone healing and post-traumatic remodeling – including resolution of bone oedema on magnetic resonance imaging – while reactivating mineralisation pathways to enhance bone density, optimise collagen architecture, and preserve functional mobility.
Packaging |
Volume |
Active Ingredient |
|---|---|---|
| Tablets | 30 Tablets | MESOPOROSIL®: 30 mg — of which bioactive Silicium: 14 mg |
Application:
RECOMMENDED USE
PRECAUTIONS
STORAGE
Studies show that serum silicium (Si) levels decline with age, particularly in women, correlating with reduced bone mineral density and increased connective tissue fragility (Ref: 1,2). Silicium supports collagen synthesis and
bone matrix formation, making serum silicium deficiency a contributing factor to age-related osteoporosis and joint deformities (3).
ACTIVATED
The unique mesoporous 3D structure maximises the available surface area, enabling silicium to remain in its bioactive monomeric form (orthosilicic acid).
ABSORBED:
In vitro and in vivo studies (Ussing chamber assays) demonstrate enhanced intestinal permeability and superior solubility compared to conventional silicium sources.
ASSIMILATED:
Following absorption, silicium contributes to collagen synthesis and bone mineralisation, supporting integration into body structures and plasma elimination over time.
